This article has been updated to include comments from PerkinElmer's Q2 conference call.

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday a 1 percent increase in its second quarter revenues, or 8 percent on a constant-currency basis.

For the three months ended June 28, PerkinElmer's revenues rose to $563.9 million from $556.2 million for the same period a year ago,beating analysts' average estimate of $555.5 million. The company reported organic revenue growth of 4 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.